A novel mechanism of sodium iodide symporter repression in differentiated thyroid cancer
Open Access
- 15 September 2009
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 122 (18), 3393-3402
- https://doi.org/10.1242/jcs.045427
Abstract
Differentiated thyroid cancers and their metastases frequently exhibit reduced iodide uptake, impacting on the efficacy of radioiodine ablation therapy. PTTG binding factor (PBF) is a proto-oncogene implicated in the pathogenesis of thyroid cancer. We recently reported that PBF inhibits iodide uptake, and have now elucidated a mechanism by which PBF directly modulates sodium iodide symporter (NIS) activity in vitro. In subcellular localisation studies, PBF overexpression resulted in the redistribution of NIS from the plasma membrane into intracellular vesicles, where it colocalised with the tetraspanin CD63. Cell-surface biotinylation assays confirmed a reduction in plasma membrane NIS expression following PBF transfection compared with vector-only treatment. Coimmunoprecipitation and GST-pull-down experiments demonstrated a direct interaction between NIS and PBF, the functional consequence of which was assessed using iodide-uptake studies in rat thyroid FRTL-5 cells. PBF repressed iodide uptake, whereas three deletion mutants, which did not localise within intracellular vesicles, lost the ability to inhibit NIS activity. In summary, we present an entirely novel mechanism by which the proto-oncogene PBF binds NIS and alters its subcellular localisation, thereby regulating its ability to uptake iodide. Given that PBF is overexpressed in thyroid cancer, these findings have profound implications for thyroid cancer ablation using radioiodine.Keywords
This publication has 56 references indexed in Scilit:
- Identification of in Vivo Phosphorylation Sites and Their Functional Significance in the Sodium Iodide SymporterPublished by Elsevier BV ,2007
- PI3K activation is associated with intracellular sodium/iodide symporter protein expression in breast cancerBMC Cancer, 2007
- Functional Characterization of Human Thyroid Tissue with ImmunohistochemistryThyroid®, 2007
- RAPID COMMUNICATION: Predominant Intracellular Overexpression of the Na+/I- Symporter (NIS) in a Large Sampling of Thyroid Cancer CasesJournal of Clinical Endocrinology & Metabolism, 2001
- Expression of the Sodium Iodide Symporter and Thyroglobulin Genes Are Reduced in Papillary Thyroid CancerLaboratory Investigation, 2001
- Expressions of Human Sodium Iodide Symporter mRNA in Primary and Metastatic Papillary Thyroid CarcinomasThyroid®, 2000
- Na+/I- Symporter Distribution in Human Thyroid Tissues: An Immunohistochemical StudyJournal of Clinical Endocrinology & Metabolism, 1998
- Cloning of a Novel Human Putative Type Ia Integral Membrane Protein Mapping to 21q22.3Genomics, 1998
- Retinoic Acid Increases Sodium/Iodide Symporter mRNA Levels in Human Thyroid Cancer Cell Lines and Suppresses Expression of Functional Symporter in Nontransformed FRTL-5 Rat Thyroid CellsBiochemical and Biophysical Research Communications, 1997
- Cloning of the Human Sodium Iodide SymporterBiochemical and Biophysical Research Communications, 1996